Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-lysine + L-arginine is a combination of two naturally occurring amino acids, both of which are essential for human health. L-lysine is an essential amino acid required for protein synthesis, calcium absorption, collagen formation, and energy production. L-arginine is a semi-essential amino acid involved in protein synthesis and serves as a precursor to nitric oxide, which acts as a vasodilator to improve blood flow. The combination has been studied as a dietary supplement for its potential to reduce anxiety by normalizing hormonal stress responses in individuals with high trait anxiety. Additionally, the pair may enhance bone-building cell activity and collagen production. Both amino acids share transport mechanisms into the brain that can be competitively inhibited by high concentrations of either compound[2][3][6]. This combination is primarily used as a dietary supplement rather than as an approved pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-lysine + L-arginine.